Consensus GE HealthCare Technologies Inc.

Equities

GEHC

US36266G1076

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-08 pm EDT			5-day change	1st Jan Change
81.11 ^USD	-0.39%		+3.64%	+4.90%

May. 05	GE HealthCare Unveils SIGNA MAGNUS, an FDA 510(K) Pending Head-Only Magnetic Resonance (MR) Scanner Designed to Explore Advance Advancements in Neuro Science	CI
May. 01	Mizuho Adjusts Price Target on GE HealthCare Technologies to $105 From $110	MT

Evolution of the average Target Price on GE HealthCare Technologies Inc.

Price target over the last 5 years

History of analyst recommendation changes

e28fb9317b90550a8117d41a51a.OuEWapsfIFyzKZNXMozqLANhKAEPmttDUj6d3j2dr3s.V7dVE_lRFBvJYsQRY_3eSDotREpIzqoXIXfvnw6syU5S1HBY0lVCNYVM_A~8fb28e989cef51fb4b420def879b1038

Analyst Recommendations on GE HealthCare Technologies Inc.

Mizuho Adjusts Price Target on GE HealthCare Technologies to $105 From $110	May. 01	MT
Jefferies Adjusts Price Target on GE HealthCare Technologies to $87 From $92	May. 01	MT
Wells Fargo Cuts GE HealthCare Technologies' Price Target to $88 From $90	Apr. 30	MT
Piper Sandler Adjusts GE HealthCare Technologies' Price Target to $92 From $94	Apr. 30	MT
Evercore ISI Adjusts GE HealthCare Technologies' Price Target to $96 From $100	Apr. 30	MT
Mizuho Adjusts Price Target on GE HealthCare Technologies to $110 From $96, Maintains Buy Rating	Apr. 11	MT
Citigroup Raises Price Target on GE HealthCare Technologies to $103 From $88, Maintains Buy Rating	Apr. 03	MT
Argus Research Raises GE HealthCare Technologies' Price Target to $110 From $80, Maintains Buy Rating	Apr. 01	MT
HSBC Initiates GE HealthCare Technologies With Buy Rating, $100 Price Target	Feb. 15	MT
UBS Upgrades GE HealthCare Technologies to Neutral From Sell, Raises Price Target to $88 From $66	Feb. 12	MT
Mizuho Adjusts Price Target on GE HealthCare Technologies to $96 From $94, Maintains Buy Rating	Feb. 07	MT
US stocks end higher; focus on earnings, rates	Feb. 06	RE
S&P 500 closes up; focus on earnings and US interest rates	Feb. 06	RE
US Equity Indexes Mixed, Treasury Yields Slump as Fed Officials Mull Rate Outlook	Feb. 06	MT
Wall St mixed with focus on earnings, rate-cut expectations	Feb. 06	RE
Wall St set for muted open; earnings, rate-cut expectations in focus	Feb. 06	RE
Futures subdued with focus on pharma earnings, rate expectations	Feb. 06	RE
North American Morning Briefing : Rate Doubts Keep Pressure on Stocks; More Earnings in Focus	Feb. 06	DJ
Morgan Stanley Cuts Price Target on GE HealthCare Technologies to $74 From $78, Maintains Equal-Weight Rating	Dec. 04	MT
Jefferies Initiates GE HealthCare Technologies at Hold Rating With $80 Price Target	Nov. 30	MT
GE HEALTHCARE : Jefferies initiates 'hold' coverage	Nov. 30	CF
GE HEALTHCARE : collaboration agreement with Novo Nordisk	Nov. 30	CF
ANALYST RECOMMENDATIONS : Blackrock, Costco, Dollar Tree, Duke Energy, Snowflake...	Nov. 30
UBS Downgrades GE HealthCare Technologies to Sell From Neutral, Adjusts Price Target to $66 From $86	Nov. 27	MT
GE HEALTHCARE : UBS downgrades its recommendation	Nov. 27	CF

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

81.11 USD

Average target price

93.71 USD

Spread / Average Target

+15.53%

High Price Target

105 USD

Spread / Highest target

+29.45%

Low Price Target

86 USD

Spread / Lowest Target

+6.03%

Consensus detail

Consensus revision (last 18 months)

Analysts covering GE HealthCare Technologies Inc.

Mizuho Securities
Jefferies & Co.
Piper Sandler
Wells Fargo Securities
Evercore ISI
Citigroup
Argus
HSBC
UBS
Morgan Stanley
BofA Securities
Oppenheimer
BTIG
Redburn

Ratings for GE HealthCare Technologies Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar